Sort by
Keyphrases
DNA Vaccine
100%
Virus Pathogenesis
100%
Zika Virus
100%
In Vivo Protection
100%
Passive Immunity
100%
Zika Virus Infection
100%
Active Immunization
100%
Envelope Protein
50%
Premembrane
50%
Nonhuman Primate
33%
Viral Challenge
33%
Cellular Immunity
16%
Humoral Immunity
16%
Protein-DNA Complex
16%
Virus
16%
Immune Response
16%
Immunogen
16%
Immunization
16%
DNA Sequencing
16%
Mouse Model
16%
Mosquito-borne
16%
Disease Prevention
16%
Weight Loss
16%
Vaccine Approaches
16%
Exposure Risk
16%
Vaccine Response
16%
Antigen-specific
16%
Interferon-α (IFN-α)
16%
IFNAR1
16%
Model Support
16%
In Vivo Efficacy
16%
Brain Tissue
16%
Electroporation
16%
Synthetic DNA
16%
% Protection
16%
Virus Diseases
16%
Passive Transfer
16%
IFNAR Mice
16%
Immune Serum
16%
Viral Pathology
16%
Congenital Abnormalities
16%
Neutralization Activity
16%
Infection Spread
16%
Guillain-Barré Syndrome
16%
Microcephaly
16%
Vaccine Target
16%
Disease Spread
16%
In Vitro Evaluation
16%
Virus Control
16%
Associated Weights
16%
DNA Delivery
16%
Global Spread
16%
In Vitro Development
16%
Immunological Activity
16%
Plasmid Construct
16%
Pharmacology, Toxicology and Pharmaceutical Science
Virus Pathogenesis
100%
Zika Virus
100%
Zika Fever
100%
DNA Immunization
100%
Envelope Protein
50%
Infection
33%
Diseases
33%
Mouse Model
16%
Receptor
16%
Gene Delivery
16%
Synthetic DNA
16%
Interferon
16%
Antiserum
16%
Congenital Disorder
16%
Microcephaly
16%
Guillain Barre Syndrome
16%
Immunology and Microbiology
Viral Disease
100%
Zika Virus
100%
Active Immunization
100%
DNA Immunization
100%
Infection
22%
Humoral Immunity
11%
Adoptive Immunity
11%
Immune Response
11%
Mouse Model
11%
Plasmid
11%
interferon
11%
Antigen Specificity
11%
Neutralization
11%
Gene Targeting
11%
Antiserum
11%
Electroporation
11%
Brain Tissue
11%
Guillain-Barré Syndrome
11%
Virus
11%
In Vitro
11%